About Evelyn Schulz

Evelyn Schulz is a partner in Noerr’s healthcare and life sciences practice. She focuses on regulatory issues in healthcare and life sciences transactions and regularly advises national and international clients on M&A projects involving pharmaceutical, healthcare, digital health and other regulated business models. Her work includes regulatory due diligence, product compliance, distribution structures, market access-related questions, contractual arrangements and the assessment of healthcare-specific risks in transactions. Evelyn also advises on standalone regulatory matters, including telehealth platforms, pharmaceutical distribution, cannabis/CBD-related business models and advanced therapy medicinal products.

Contributions to Global Practice Guides

Healthcare M&A Trends and Developments in Germany

Healthcare M&A Law and Practice in Germany

Chambers and Partners make no representation or endorsement of the quality and services supplied by companies or firms that may be found on this website. In no event will Chambers and Partners be liable for any damages including, without limitation, indirect or consequential damages, or any damages whatsoever arising from use or loss of use, data, or profits, whether in action of contract, negligence or other tort action, arising out of or in connection with the use of the website.